For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Strattera (Atomoxetine) | Atomoxetine monotherapy up o 1.2 mg/kg/day or 120 mg/day. | None | None | 0 | 45 | 45 | 45 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Dry Mouth | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Gastrointestinal | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Insomnia | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Tired/fatigued | None | General disorders | None | View |
| Headache | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Decreased appetite | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Warmth/flushing/sweating | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Colds/allergies/infections | SYSTEMATIC_ASSESSMENT | Immune system disorders | None | View |
| Lightheaded/dizzy | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Musculoskeletal discomfort | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Tension/jitteriness | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Mood change | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| Sexual function | SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | None | View |
| Urinary hesitancy | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Neurologic | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Vision/ocular | SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |
| Feeling cold | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Injury | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| Muscle twitch/tremor | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Impaired concentration | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Palpitations | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Tingling sensation | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Vivid dreams | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| Anxiety | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| Bad taste | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Chest discomfort | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Skin changes | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Increased appetite | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Paresthesia | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Shortness of breath | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Urinary incontinence | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |